Difficulty: Medium
Average Score: 80%
Practice
A 66-year-old woman who has smoked two packs of cigarettes per day for 50 years has chronic bronchitis. She has tried to quit five times in the past but felt she could not go long without a cigarette. The nicotine in her cigarettes stimulates many cells in her body by binding certain receptors. Which of the following drugs blocks nicotinic receptors?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Hexamethonium, which is a ganglionic blocker that blocks nicotinic receptors. Nicotine in cigarettes binds to nicotinic receptors, stimulating various cells in the body. By blocking these receptors with Hexamethonium, the effects of nicotine can be antagonized.
Option A) Atropine is a muscarinic receptor antagonist, not a nicotinic receptor blocker, so it is incorrect. Option B) Bethanechol is a muscarinic receptor agonist, not a nicotinic receptor blocker, making it an incorrect choice. Option D) Metoprolol is a beta-adrenergic receptor blocker and does not act on nicotinic receptors, so it is also incorrect in this context.
Educationally, understanding the pharmacology of drugs that target specific receptors is crucial in pharmacotherapy. This question highlights the importance of knowing the mechanism of action of drugs to choose the appropriate treatment for a patient's condition. It also underscores the significance of recognizing the effects of chronic nicotine exposure on receptor function in the body.
Option A) Atropine is a muscarinic receptor antagonist, not a nicotinic receptor blocker, so it is incorrect. Option B) Bethanechol is a muscarinic receptor agonist, not a nicotinic receptor blocker, making it an incorrect choice. Option D) Metoprolol is a beta-adrenergic receptor blocker and does not act on nicotinic receptors, so it is also incorrect in this context.
Educationally, understanding the pharmacology of drugs that target specific receptors is crucial in pharmacotherapy. This question highlights the importance of knowing the mechanism of action of drugs to choose the appropriate treatment for a patient's condition. It also underscores the significance of recognizing the effects of chronic nicotine exposure on receptor function in the body.